Prodia Widyahusada Tbk PT (PRDA.JK) stock: key figures, P/E, revenue and dividend

Health Care · Life Sciences Tools & Services · Indonesia · ISIN ID1000138001

Price
3,700.00 IDR
Market cap
3.37 tn IDR
P/E (2025)
16.28
P/S (2025)
1.48
Dividend yield
4.40 %
Net margin
9.06 %
Return on equity (ROE)
8.65 %
Return on assets (ROA)
7.67 %

Prodia Widyahusada Tbk PT financials

Fiscal year20242025
Revenue2.25 tn IDR2.28 tn IDR
Gross profit1.35 tn IDR1.13 tn IDR
Operating income300.50 bn IDR227.11 bn IDR
EBIT345.43 bn IDR266.23 bn IDR
Net income270.20 bn IDR206.79 bn IDR
Diluted EPS – continuing operations288.21 IDR227.25 IDR

Full history since 2013, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Prodia Widyahusada Tbk PT

PT Prodia Widyahusada Tbk provides clinical laboratory services in Indonesia. The company offers test services, such as genomic, laboratory, and non-laboratory tests, as well as test panels; doctor consultation and teleconsultation services; vaccines; home services; and research support services. It also engages in the operation of Prodia Health Care, a personalized medicine-based wellness clinic; and specialty clinics, including Prodia Children, Prodia Women, and Prodia Senior. The company was founded in 1973 and is headquartered in Jakarta Pusat, Indonesia. PT Prodia Widyahusada Tbk operates as a subsidiary of PT Prodia Utama.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.